Financial statements Laerdal Medical Poland
Cash flow statement of Laerdal Medical Poland
Company age:
Age:
23 y. 3 m.
Share capital:
Share capital:
50 000 PLN
Cash inflows of LAERDAL MEDICAL POLAND
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Net cash from operating expenses | 2 913 400,80 | 2 241 957,91 | 5 363 374,22 | 3 059 145,70 |
| Net cash flow from investing activities | 522 871,67 | -77 024,84 | -180 029,94 | -13 383,44 |
| Net cash flow from financial activities | -8 048 515,30 | -170 233,70 | -6 293 796,63 | -5 305 832,19 |
| Total net cash flow | -4 612 242,83 | 1 994 699,37 | -1 110 452,35 | -2 260 069,93 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.